A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

by palligoelme@gmail.com | Oct 29, 2025 | Clinical Trials

​ Conditions: Diabetes Mellitus, Type 1 Interventions: Drug: Baricitinib; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting Conditions: Diabetes Mellitus, Type 1 Interventions: Drug: Baricitinib; Drug: Placebo Sponsors: Eli Lilly and Company Not yet...

Spinal Neurorehabilitation for Veterans With SCI

by palligoelme@gmail.com | Oct 29, 2025 | Clinical Trials

​ Conditions: Spinal Cord Injuries Interventions: Diagnostic Test: Neurophysiological and anatomical testing; Device: Transcutaneous Spinal Stimulation Sponsors: VA Office of Research and Development Not yet recruiting Conditions: Spinal Cord Injuries Interventions:...

Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation

by palligoelme@gmail.com | Oct 28, 2025 | Clinical Trials

​ Conditions: Mental Function Interventions: Procedure: Propofol for fMRI; Procedure: Dexmedetomidine for fMRI; Device: Dorsolateral prefrontal cortex (DLPFC) pulsation; Device: Anterior insular cortex (AIC) pulsation; Device: Central thalamus (CT) pulsation Sponsors:...

Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation

by palligoelme@gmail.com | Oct 28, 2025 | Clinical Trials

​ Conditions: Dentatorubral-Pallidoluysian Atrophy Interventions: Drug: nL-ATN1-001 Sponsors: n-Lorem Foundation; Dell Children’s Medical Center of Central Texas Not yet recruiting Conditions: Dentatorubral-Pallidoluysian Atrophy Interventions: Drug: nL-ATN1-001...

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

by palligoelme@gmail.com | Oct 28, 2025 | Clinical Trials

​ Conditions: HFrEF – Heart Failure With Reduced Ejection Fraction; HFpEF – Heart Failure With Preserved Ejection Fraction; Group 2 Pulmonary Hypertension Interventions: Drug: JK07 Sponsors: Salubris Biotherapeutics Inc Not yet recruiting Conditions: HFrEF...

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

by palligoelme@gmail.com | Oct 28, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: survodutide Sponsors: Boehringer Ingelheim Not yet recruiting Conditions: Healthy Interventions: Drug: survodutide Sponsors: Boehringer Ingelheim Not yet recruiting